SAFETY DATA SHEET

Etoricoxib Formulation
Version
9.0

Revision Date:
2024/04/06

SDS Number:
26548-00025

Date of last issue: 2023/09/29
Date of first issue: 2014/10/29

1. PRODUCT AND COMPANY IDENTIFICATION
Chemical product name:

Etoricoxib Formulation

Supplier's company name, address and phone number
Company name of supplier: Organon & Co.
Address:

30 Hudson Street, 33nd floor
Jersey City, New Jersey, U.S.A 07302

Telephone:+1-551-430-6000

E-mail address:

EHSSTEWARD@organon.com

Emergency telephone number :+1-215-631-6999

Recommended use of the chemical and restrictions on use
Recommended use: Pharmaceutical
Restrictions on use: Not applicable

2. HAZARDS IDENTIFICATIONGHS classification of chemical product
Carcinogenicity (Inhalation): Category 2
Reproductive toxicity:

Category 2

Specific target organ toxicity repeated exposure (Oral):

Category 2 (Kidney, Liver, Gastrointestinal tract)

Short-term (acute) aquatic
hazard:Category 3

Long-term (chronic) aquatic
hazard:Category 2

GHS label elements
Hazard pictograms:

Signal word:

Warning

Hazard statements:

H351 Suspected of causing cancer if inhaled.
H361d Suspected of damaging the unborn child.
H373 May cause damage to organs (Kidney, Liver, Gastroin1 / 19

SAFETY DATA SHEET

Etoricoxib Formulation
Version
9.0

Revision Date:
2024/04/06

SDS Number:
26548-00025

Date of last issue: 2023/09/29
Date of first issue: 2014/10/29

testinal tract) through prolonged or repeated exposure if swallowed.
H402 Harmful to aquatic life.
H411 Toxic to aquatic life with long lasting effects.
Precautionary statements:

Prevention:
P201 Obtain special instructions before use.
P202 Do not handle until all safety precautions have been readand understood.
P260 Do not breathe dust.
P273 Avoid release to the environment.
P280 Wear protective gloves/ protective clothing/ eye protection/ face protection.
Response:
P308 + P313 IF exposed or concerned: Get medical advice/attention.
P391 Collect spillage.
Storage:
P405 Store locked up.
Disposal:
P501 Dispose of contents/ container to an approved waste
disposal plant.

Other hazards which do not result in classification
Important symptoms and out- : Dust contact with the eyes can lead to mechanical irritation.
lines of the emergency asContact with dust can cause mechanical irritation or drying ofsumed
the skin.
May form explosive dust-air mixture during processing, handling or other means.
3. COMPOSITION/INFORMATION ON INGREDIENTS
Substance / Mixture:

MixtureComponents
Chemical name
Cellulose
Etoricoxib
Titanium dioxide

CAS-No.
9004-34-6
202409-33-4
13463-67-7

Concentration (% w/w)>= 30 - < 40>= 25 - < 30
> 0 - < 10

ENCS No.

1-558, 5-5225

4. FIRST AID MEASURES
General advice:

In the case of accident or if you feel unwell, seek medical advice immediately.
When symptoms persist or in all cases of doubt seek medical
advice.
2 / 19SAFETY DATA SHEET

Etoricoxib Formulation
Version
9.0

Revision Date:
2024/04/06

SDS Number:
26548-00025

If inhaled:

In case of skin contact:

In case of eye contact:

If swallowed:

Most important symptoms
and effects, both acute anddelayed:Protection of first-aiders:

Notes to physician:

Date of last issue: 2023/09/29
Date of first issue: 2014/10/29

If inhaled, remove to fresh air.
Get medical attention.
In case of contact, immediately flush skin with soap and plentyof water.
Remove contaminated clothing and shoes.
Get medical attention.
Wash clothing before reuse.
Thoroughly clean shoes before reuse.
If in eyes, rinse well with water.
Get medical attention if irritation develops and persists.
If swallowed, DO NOT induce vomiting.
Get medical attention.
Rinse mouth thoroughly with water.
Suspected of causing cancer if inhaled.
Suspected of damaging the unborn child.
May cause damage to organs through prolonged or repeatedexposure if swallowed.
Contact with dust can cause mechanical irritation or drying of
the skin.
Dust contact with the eyes can lead to mechanical irritation.
First Aid responders should pay attention to self-protection,and use the recommended personal protective equipment
when the potential for exposure exists (see section 8).
Treat symptomatically and supportively.

5. FIREFIGHTING MEASURES
Suitable extinguishing media:

Water spray
Alcohol-resistant foam
Carbon dioxide (CO2)
Dry chemical
None known.

Unsuitable extinguishingmedia
Specific hazards during firefighting::

Avoid generating dust; fine dust dispersed in air in sufficientconcentrations, and in the presence of an ignition source is apotential dust explosion hazard.
Exposure to combustion products may be a hazard to health.

Hazardous combustion products:

Carbon oxides
Nitrogen oxides (NOx)Sulphur oxides
Chlorine compounds
Metal oxides
Oxides of phosphorus

Specific extinguishing methods:

Special protective equipment
for firefighters:

Use extinguishing measures that are appropriate to local circumstances and the surrounding environment.
Use water spray to cool unopened containers.
Remove undamaged containers from fire area if it is safe to doso.
Evacuate area.
In the event of fire, wear self-contained breathing apparatus.
Use personal protective equipment.
3 / 19SAFETY DATA SHEET

Etoricoxib Formulation
Version
9.0

Revision Date:
2024/04/06

SDS Number:
26548-00025

Date of last issue: 2023/09/29
Date of first issue: 2014/10/29

6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protec- :tive equipment and emergency procedures

Use personal protective equipment.
Follow safe handling advice (see section 7) and personal protective equipment recommendations (see section 8).

Environmental precautions:

Avoid release to the environment.
Prevent further leakage or spillage if safe to do so.
Retain and dispose of contaminated wash water.
Local authorities should be advised if significant spillages
cannot be contained.

Methods and materials forcontainment and cleaning up:

Sweep up or vacuum up spillage and collect in suitable container for disposal.
Avoid dispersal of dust in the air (i.e., clearing dust surfaces
with compressed air).
Dust deposits should not be allowed to accumulate on surfaces, as these may form an explosive mixture if they are released into the atmosphere in sufficient concentration.
Local or national regulations may apply to releases and disposal of this material, as well as those materials and items
employed in the cleanup of releases. You will need to determine which regulations are applicable.
Sections 13 and 15 of this SDS provide information regarding
certain local or national requirements.

Handling
Technical measures:

Local/Total ventilation
Advice on safe handling::

Avoidance of contact
Hygiene measures::

Static electricity may accumulate and ignite suspended dust
causing an explosion.
Provide adequate precautions, such as electrical grounding
and bonding, or inert atmospheres.
Use only with adequate ventilation.
Do not breathe dust.
Do not swallow.
Avoid contact with eyes.
Avoid prolonged or repeated contact with skin.
Handle in accordance with good industrial hygiene and safety
practice, based on the results of the workplace exposure assessment
Minimize dust generation and accumulation.
Keep container closed when not in use.
Keep away from heat and sources of ignition.
Take precautionary measures against static discharges.
Take care to prevent spills, waste and minimize release to theenvironment.
Oxidizing agents
If exposure to chemical is likely during typical use, provide eye

7. HANDLING AND STORAGE

4 / 19SAFETY DATA SHEET

Etoricoxib Formulation
Version
9.0

Revision Date:
2024/04/06

SDS Number:
26548-00025

Date of last issue: 2023/09/29
Date of first issue: 2014/10/29

flushing systems and safety showers close to the working
place.
When using do not eat, drink or smoke.
Wash contaminated clothing before re-use.
Storage
Conditions for safe storage:

Materials to avoid:

Packaging material:

Keep in properly labelled containers.
Store locked up.
Store in accordance with the particular national regulations.
Do not store with the following product types:
Strong oxidizing agents
Unsuitable material: None known.

8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Threshold limit value and permissible exposure limits for each component in the work environment
Components

CAS-No.

Value type
(Form ofexposure)

Cellulose
Etoricoxib

9004-34-6
202409-33-4

TWA
TWA

Titanium dioxide

13463-67-7

Engineering measures

Control parameters / Reference
concentration /Permissible concentration
10 mg/m3
400 ug/m3 (OEB
2)
1.5 mg/m3(Titanium)

Basis

ACGIH
Internal

OEL-M
JP OEL(Respirable
JSOH
particulatematter)Further information: Group 2B: possibly carcinogenic to humans
OEL-M (Total 2 mg/m3
JP OELparticulate(Titanium)
JSOH
matter)Further information: Group 2B: possibly carcinogenic to humans:

Ensure adequate ventilation, especially in confined areas.
Minimize workplace exposure concentrations.
Apply measures to prevent dust explosions.
Ensure that dust-handling systems (such as exhaust ducts,
dust collectors, vessels, and processing equipment) are designed in a manner to prevent the escape of dust into thework area (i.e., there is no leakage from the equipment).

Personal protective equipment
Respiratory protection: If adequate local exhaust ventilation is not available or exposure assessment demonstrates exposures outside the recommended guidelines, use respiratory protection.
Filter type
: Particulates type
Hand protection

5 / 19SAFETY DATA SHEET

Etoricoxib Formulation
Version
9.0

Revision Date:
2024/04/06

SDS Number:
26548-00025

Date of last issue: 2023/09/29
Date of first issue: 2014/10/29

Material:

Chemical-resistant gloves

Remarks:

Eye protection:

Skin and body protection:

Choose gloves to protect hands against chemicals dependingon the concentration and quantity of the hazardous substance and specific to place of work. Breakthrough time is notdetermined for the product. Change gloves often! For special
applications, we recommend clarifying the resistance tochemicals of the aforementioned protective gloves with theglove manufacturer. Wash hands before breaks and at theend of workday.
Wear the following personal protective equipment:
Safety goggles
Select appropriate protective clothing based on chemical
resistance data and an assessment of the local exposure
potential.
Skin contact must be avoided by using impervious protective
clothing (gloves, aprons, boots, etc).

9. PHYSICAL AND CHEMICAL PROPERTIES
Physical state:

powderColour:colouredOdour:

odourlessOdour Threshold:

No data available

Melting point/freezing point:

No data available

Boiling point, initial boilingpoint and boiling range:

No data available

Flammability (solid, gas):

May form explosive dust-air mixture during processing, handling or other means.

Flammability (liquids):

No data available

Lower explosion limit and upper explosion limit / flammability limit
Upper explosion limit / Up- : No data available
per flammability limit
Lower explosion limit /Lower flammability limit:

No data available

Flash point:

No data available

Decomposition temperature:

No data available

pH:

No data available

Evaporation rate:

No data available

6 / 19SAFETY DATA SHEET

Etoricoxib Formulation
Version
9.0

Revision Date:
2024/04/06

SDS Number:
26548-00025

Date of last issue: 2023/09/29
Date of first issue: 2014/10/29

Auto-ignition temperature:

No data available

Viscosity
Viscosity, kinematic:

No data available

Solubility(ies)
Water solubility:

No data available

Partition coefficient: noctanol/water:

No data available

Vapour pressure:

No data available

Density and / or relative density
Relative density:

No data available

Relative vapour density:

No data available

Explosive properties:

Not explosive

Oxidizing properties:

The substance or mixture is not classified as oxidizing.

Molecular weight:

No data available

Particle characteristics
Particle size:

No data available

Reactivity
Chemical stability
Possibility of hazardous reactions:::

Not classified as a reactivity hazard.
Stable under normal conditions.
May form explosive dust-air mixture during processing, handling or other means.
Can react with strong oxidizing agents.

Conditions to avoid:

Incompatible materials
Hazardous decomposition
products::

Heat, flames and sparks.
Avoid dust formation.
Oxidizing agents
No hazardous decomposition products are known.

10. STABILITY AND REACTIVITY

11. TOXICOLOGICAL INFORMATION
Information on likely routes of :exposure

Inhalation
Skin contact
Ingestion
Eye contact

7 / 19SAFETY DATA SHEET

Etoricoxib Formulation
Version
9.0

Revision Date:
2024/04/06

SDS Number:
26548-00025

Date of last issue: 2023/09/29
Date of first issue: 2014/10/29

Acute toxicity
Not classified based on available information.
Product:
Acute oral toxicity:

Acute toxicity estimate: > 2,000 mg/kg
Method: Calculation method

Cellulose:
Acute oral toxicity:

LD50 (Rat): > 5,000 mg/kg

Acute inhalation toxicity:

LC50 (Rat): > 5.8 mg/l
Exposure time: 4 h
Test atmosphere: dust/mist

Acute dermal toxicity:

LD50 (Rabbit): > 2,000 mg/kg

Etoricoxib:
Acute oral toxicity:

LD50 (Rat): 1,499 mg/kg

Components:

LD50 (Mouse): 1,499 mg/kg
Acute toxicity (other routes of :administration)

LD50 (Rat): 238 mg/kg
Application Route: Intraperitoneal
LD50 (Mouse): 599 mg/kg
Application Route: Intraperitoneal

Titanium dioxide:
Acute oral toxicity:

LD50 (Rat): > 5,000 mg/kg

Acute inhalation toxicity:

LC50 (Rat): > 6.82 mg/l
Exposure time: 4 h
Test atmosphere: dust/mist
Assessment: The substance or mixture has no acute inhalation toxicity

Skin corrosion/irritation
Not classified based on available information.
Components:
Etoricoxib:
SpeciesResult::RabbitNo skin irritation

Titanium dioxide:
Species:

Rabbit8 / 19SAFETY DATA SHEET

Etoricoxib Formulation
Version
9.0

Revision Date:
2024/04/06

ResultSDS Number:
26548-00025:

Date of last issue: 2023/09/29
Date of first issue: 2014/10/29

No skin irritation

Serious eye damage/eye irritation
Not classified based on available information.
Components:
Etoricoxib:
SpeciesResult::RabbitMild eye irritation

Titanium dioxide:
SpeciesResult::RabbitNo eye irritation

Respiratory or skin sensitisation
Skin sensitisation
Not classified based on available information.
Respiratory sensitisation
Not classified based on available information.
Components:
Etoricoxib:
Test Type
Exposure routes
Species
Assessment
Result:::::Local lymph node assay (LLNA)
Skin contact
Mouse
Did not cause sensitisation on laboratory animals.
negative

Titanium dioxide:
Test Type
Exposure routes
SpeciesResult::::Local lymph node assay (LLNA)
Skin contact
Mouse
negative

Germ cell mutagenicity
Not classified based on available information.
Components:
Cellulose:
Genotoxicity in vitro:

Test Type: Bacterial reverse mutation assay (AMES)
Result: negative
Test Type: In vitro mammalian cell gene mutation test
Result: negative

9 / 19SAFETY DATA SHEET

Etoricoxib Formulation
Version
9.0

Revision Date:
2024/04/06

SDS Number:
26548-00025

Date of last issue: 2023/09/29
Date of first issue: 2014/10/29

Genotoxicity in vivo:

Test Type: Mammalian erythrocyte micronucleus test (in vivo
cytogenetic assay)
Species: Mouse
Application Route: Ingestion
Result: negative

Etoricoxib:
Genotoxicity in vitro:

Test Type: reverse mutation assay
Result: negative
Test Type: In vitro mammalian cell gene mutation test
Test system: human lymphoblastoid cells
Result: negative
Test Type: Chromosomal aberration
Test system: Chinese hamster ovary cells
Result: negative
Test Type: Alkaline elution assay
Result: negative

Genotoxicity in vivo:

Test Type: Chromosomal aberration
Species: Rat
Cell type: Bone marrow
Application Route: Oral
Result: negative
Test Type: Alkaline elution assay
Species: Rat
Application Route: Oral
Result: negative

Titanium dioxide:
Genotoxicity in vitro:

Test Type: Bacterial reverse mutation assay (AMES)
Result: negative

Genotoxicity in vivo:

Test Type: In vivo micronucleus test
Species: Mouse
Result: negative

Carcinogenicity
Suspected of causing cancer if inhaled.
Components:
Cellulose:
Species
Application RouteExposure time
Result

:
:
:
:

Rat
Ingestion
72 weeks
negative
10 / 19

SAFETY DATA SHEET

Etoricoxib Formulation
Version
9.0

Revision Date:
2024/04/06

SDS Number:
26548-00025

Date of last issue: 2023/09/29
Date of first issue: 2014/10/29

Etoricoxib:
Species
Application RouteExposure time
Result::::Rat, male and female
oral (gavage)
2 Years
positive

Species
Application RouteExposure time
Result::::Mouse, male and female
oral (gavage)
2 Years
negative

Titanium dioxide:
Species
Application RouteExposure time
MethodResultRemarks

:
:
:
:
:
:

Rat
inhalation (dust/mist/fume)
2 Years
OECD Test Guideline 453
positive
The mechanism or mode of action may not be relevant in
humans.

:Limited evidence of carcinogenicity in inhalation studies withanimals.

Carcinogenicity - Assessment

Reproductive toxicity
Suspected of damaging the unborn child.
Components:
Cellulose:
Effects on fertility

Effects on foetal development

Etoricoxib:
Effects on fertility:

Test Type: One-generation reproduction toxicity study
Species: Rat
Application Route: Ingestion
Result: negative:

Test Type: Fertility/early embryonic development
Species: Rat
Application Route: Ingestion
Result: negative:

Test Type: Fertility/early embryonic development
Species: Rat, female
Application Route: Oral
General Toxicity - Parent: NOAEL: 10 mg/kg body weight
Result: positive
Test Type: Fertility/early embryonic development
Species: Rat, male
Application Route: Oral
Result: negative
11 / 19

SAFETY DATA SHEET

Etoricoxib Formulation
Version
9.0

Revision Date:
2024/04/06

Effects on foetal development

SDS Number:
26548-00025:

Date of last issue: 2023/09/29
Date of first issue: 2014/10/29

Species: Rat
Application Route: Oral
Result: positive
Species: Rabbit
Application Route: Oral
Result: positive

Reproductive toxicity - Assessment:

Some evidence of adverse effects on development, based onanimal experiments.

STOT - single exposure
Not classified based on available information.
STOT - repeated exposure
May cause damage to organs (Kidney, Liver, Gastrointestinal tract) through prolonged or repeated exposure if swallowed.
Components:
Etoricoxib:
Exposure routes
Target Organs
Assessment:::

Ingestion
Kidney, Liver, Gastrointestinal tract
May cause damage to organs through prolonged or repeatedexposure.

Cellulose:
Species
NOAEL
Application RouteExposure time

:
:
:
:

Rat
>= 9,000 mg/kg
Ingestion
90 Days

Etoricoxib:
Species
LOAEL
Application RouteExposure timeTarget Organs

:
:
:
:
:

Rat
30 mg/kg
oral (gavage)
27 Weeks
Gastrointestinal tract, KidneySpecies
NOAEL
Application RouteExposure timeTarget Organs

:
:
:
:
:

Rat
30 mg/kg
oral (gavage)
53 Weeks
Liver

Species:Dog

Repeated dose toxicity
Components:

12 / 19

SAFETY DATA SHEET

Etoricoxib Formulation
Version
9.0

Revision Date:
2024/04/06

SDS Number:
26548-00025

Date of last issue: 2023/09/29
Date of first issue: 2014/10/29

NOAEL
Application RouteExposure timeTarget Organs

:
:
:
:

50 mg/kg
oral (gavage)
53 Weeks
Liver

Species
LOAEL
Application RouteExposure timeTarget Organs

:
:
:
:
:

Dog
200 mg/kg
oral (gavage)
14 Weeks
Gastrointestinal tract, Kidney

Titanium dioxide:
Species
NOAEL
Application RouteExposure time

:
:
:
:

Rat
24,000 mg/kg
Ingestion
28 DaysSpecies
NOAEL
Application RouteExposure time

:
:
:
:

Rat
10 mg/m3
inhalation (dust/mist/fume)
2 yr

Aspiration toxicity
Not classified based on available information.
Experience with human exposure
Components:
Etoricoxib:
Ingestion:

Symptoms: upper respiratory tract infection, Headache, hypertension, Diarrhoea, urinary tract infection, flu-like symptoms,
heartburn, Nausea, bronchitis, Dizziness, asthenia, Rash,
Back pain, Cough, Abdominal pain, pharyngitis, Oedema

Cellulose:
Toxicity to fish:

LC50 (Oryzias latipes (Japanese medaka)): > 100 mg/l
Exposure time: 48 h
Remarks: Based on data from similar materials

Etoricoxib:
Toxicity to fish:

LC50 (Pimephales promelas (fathead minnow)): > 30 mg/l
Exposure time: 96 h
Method: OECD Test Guideline 203

12. ECOLOGICAL INFORMATION
Ecotoxicity
Components:

13 / 19

SAFETY DATA SHEET

Etoricoxib Formulation
Version
9.0

Revision Date:
2024/04/06

SDS Number:
26548-00025

Date of last issue: 2023/09/29
Date of first issue: 2014/10/29

Toxicity to daphnia and otheraquatic invertebrates:

EC50 (Daphnia magna (Water flea)): > 30 mg/l
Exposure time: 48 h
Method: OECD Test Guideline 202

Toxicity to algae/aquaticplants:

EC50 (Pseudokirchneriella subcapitata (green algae)): > 10
mg/l
Exposure time: 72 h
Method: OECD Test Guideline 201

Toxicity to fish (Chronic toxicity):

NOEC (Pimephales promelas (fathead minnow)): 7.93 mg/l
Exposure time: 32 d
Method: OECD Test Guideline 210

Toxicity to daphnia and other :aquatic invertebrates (Chronic toxicity)

NOEC (Daphnia magna (Water flea)): 0.75 mg/l
Exposure time: 21 d
Method: OECD Test Guideline 211

Toxicity to microorganisms

EC50: > 1,000 mg/l
Exposure time: 3 hTest Type: Respiration inhibition
Method: OECD Test Guideline 209:

NOEC: 1,000 mg/l
Exposure time: 3 hTest Type: Respiration inhibition
Method: OECD Test Guideline 209
Titanium dioxide:
Toxicity to fish:

LC50 (Oncorhynchus mykiss (rainbow trout)): > 100 mg/l
Exposure time: 96 h
Method: OECD Test Guideline 203

Toxicity to daphnia and otheraquatic invertebrates:

EC50 (Daphnia magna (Water flea)): > 100 mg/l
Exposure time: 48 h

Toxicity to algae/aquaticplants:

EC50 (Skeletonema costatum (marine diatom)): > 10,000 mg/l
Exposure time: 72 h

Toxicity to microorganisms:

EC50: > 1,000 mg/l
Exposure time: 3 hMethod: OECD Test Guideline 209

Persistence and degradability
Components:
Cellulose:
Biodegradability:

Result: Readily biodegradable.

Etoricoxib:
14 / 19

SAFETY DATA SHEET

Etoricoxib Formulation
Version
9.0

Revision Date:
2024/04/06

Biodegradability

SDS Number:
26548-00025

Date of last issue: 2023/09/29
Date of first issue: 2014/10/29:

Result: not rapidly degradable
Biodegradation: 0.2 %Exposure time: 28 d:log Pow: 2.3

Bioaccumulative potential
Components:
Etoricoxib:
Partition coefficient: noctanol/water
Mobility in soil
No data available
Hazardous to the ozone layer
Not applicable
Other adverse effects
No data available
13. DISPOSAL CONSIDERATIONS
Disposal methods
Waste from residues:

Contaminated packaging:

Dispose of in accordance with local regulations.
Do not dispose of waste into sewer.
Empty containers should be taken to an approved waste handling site for recycling or disposal.
If not otherwise specified: Dispose of as unused product.

14. TRANSPORT INFORMATIONInternational Regulations
UNRTDGUN number
Proper shipping name

:
:

Class
Packing group
LabelsEnvironmentally hazardous

:
:
:
:

IATA-DGR
UN/ID No.
Proper shipping name

:
:

Class
Packing group
LabelsPacking instruction (cargo

:
:
:
:

UN 3077
ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOLID,
N.O.S.
(Etoricoxib)
9
III
9
yes
UN 3077
Environmentally hazardous substance, solid, n.o.s.
(Etoricoxib)
9III
Miscellaneous956
15 / 19

SAFETY DATA SHEET

Etoricoxib Formulation
Version
9.0

Revision Date:
2024/04/06

aircraft)Packing instruction (passenger aircraft)
Environmentally hazardous

SDS Number:
26548-00025

Date of last issue: 2023/09/29
Date of first issue: 2014/10/29

:

956

:

yes

IMDG-CodeUN number
Proper shipping name

:
:

Class
Packing group
LabelsEmS Code
Marine pollutant

:
:
:
:
:

UN 3077
ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOLID,
N.O.S.
(Etoricoxib)
9III
9F-A, S-F
yes

Transport in bulk according to Annex II of MARPOL 73/78 and the IBC CodeNot applicable for product as supplied.
National Regulations
Refer to section 15 for specific national regulation.
Special precautions for user
The transport classification(s) provided herein are for informational purposes only, and solely
based upon the properties of the unpackaged material as it is described within this Safety Data
Sheet. Transportation classifications may vary by mode of transportation, package sizes, and variations in regional or country regulations.
ERG Code:171

15. REGULATORY INFORMATION
Related Regulations
Fire Service Law
Not applicable to dangerous materials / designated flammables.
Chemical Substance Control Law
Not applicable for Specified Chemical Substance, Monitoring Chemical Substance and Priority
Assessment Chemical Substance.
Industrial Safety and Health Law
Harmful Substances Prohibited from Manufacture
Not applicable
Harmful Substances Required Permission for Manufacture
Not applicable
Substances Prevented From Impairment of Health
Not applicable

16 / 19

SAFETY DATA SHEET

Etoricoxib Formulation
Version
9.0

Revision Date:
2024/04/06

SDS Number:
26548-00025

Date of last issue: 2023/09/29
Date of first issue: 2014/10/29

Circular concerning Information on Chemicals having Mutagenicity - Annex 2: Information
on Existing Chemicals having Mutagenicity
Not applicable
Circular concerning Information on Chemicals having Mutagenicity - Annex 1: Information
on Notified Substances having Mutagenicity
Not applicable
Substances Subject to be Notified Names
Article 57-2 (Enforcement Order Table 9)
Chemical nameTitanium(IV) oxide

Concentration (%)>0 - <10

Substances Subject to be Indicated Names
Article 57 (Enforcement Order Article 18)
Chemical nameTitanium(IV) oxide

Remarks-

Remarks-

Carcinogenic Substances (Article 577-2 of the Occupational Health and Safety Regulations)Not applicable
Ordinance on Prevention of Hazards Due to Specified Chemical Substances
Not applicable
Ordinance on Prevention of Lead Poisoning
Not applicable
Ordinance on Prevention of Tetraalkyl Lead Poisoning
Not applicable
Ordinance on Prevention of Organic Solvent Poisoning
Not applicable
Enforcement Order of the Industrial Safety and Health Law - Attached table 1 (Dangerous
Substances)
Not applicable
Poisonous and Deleterious Substances Control Law
Not applicable
Act on Confirmation, etc. of Release Amounts of Specific Chemical Substances in the Environment and Promotion of Improvements to the Management Thereof
Not applicable
High Pressure Gas Safety Act
Not applicable
Explosive Control Law
Not applicable
Vessel Safety Law
Miscellaneous dangerous substances and articles (Article 2 and 3 of rules on shipping and storage of dangerous goods and its Attached Table 1)

17 / 19

SAFETY DATA SHEET

Etoricoxib Formulation
Version
9.0

Revision Date:
2024/04/06

SDS Number:
26548-00025

Date of last issue: 2023/09/29
Date of first issue: 2014/10/29

Aviation Law
Miscellaneous dangerous substances and articles (Article 194 of The Enforcement Rules of Aviation Law and its Attached Table 1)
Marine Pollution and Sea Disaster Prevention etc Law
Bulk transportation:

Not classified as noxious liquid substance

Pack transportation:

Classified as marine pollutant

Narcotics and Psychotropics Control Act
Narcotic or Psychotropic Raw Material (Export / Import Permission)
Not applicableSpecific Narcotic or Psychotropic Raw Material (Export / Import permission)
Not applicable
Waste Disposal and Public Cleansing Law
Industrial waste
The components of this product are reported in the following inventories:
AICS: not determinedDSL:

not determined

IECSC

:

not determined

16. OTHER INFORMATIONIn this SDS, if the concentration of substances subject to notification under the Industrial Safety
and Health Law is indicated as a range, it includes cases where it is a trade secret.
Further information
Sources of key data used tocompile the Safety Data
Sheet

:

Internal technical data, data from raw material SDSs, OECD
eChem Portal search results and European Chemicals Agency, http://echa.europa.eu/

Items where changes have been made to the previous version are highlighted in the body of thisdocument by two vertical lines.
Date format:

yyyy/mm/dd

Full text of other abbreviations
ACGIH: USA. ACGIH Threshold Limit Values (TLV)
JP OEL JSOH
: Japan. The Japan Society for Occupational Health. Recommendation of Occupational Exposure Limits
ACGIH / TWA
JP OEL JSOH / OEL-M::

8-hour, time-weighted average
Occupational Exposure Limit-Mean

AIIC - Australian Inventory of Industrial Chemicals; ANTT - National Agency for Transport byLand of Brazil; ASTM - American Society for the Testing of Materials; bw - Body weight; CMR Carcinogen, Mutagen or Reproductive Toxicant; DIN - Standard of the German Institute forStandardisation; DSL - Domestic Substances List (Canada); ECx - Concentration associated with18 / 19

SAFETY DATA SHEET

Etoricoxib Formulation
Version
9.0

Revision Date:
2024/04/06

SDS Number:
26548-00025

Date of last issue: 2023/09/29
Date of first issue: 2014/10/29

x% response; ELx - Loading rate associated with x% response; EmS - Emergency Schedule;
ENCS - Existing and New Chemical Substances (Japan); ErCx - Concentration associated with
x% growth rate response; ERG - Emergency Response Guide; GHS - Globally Harmonized System; GLP - Good Laboratory Practice; IARC - International Agency for Research on Cancer; IATA
- International Air Transport Association; IBC - International Code for the Construction andEquipment of Ships carrying Dangerous Chemicals in Bulk; IC50 - Half maximal inhibitory concentration; ICAO - International Civil Aviation Organization; IECSC - Inventory of Existing Chemical Substances in China; IMDG - International Maritime Dangerous Goods; IMO - International
Maritime Organization; ISHL - Industrial Safety and Health Law (Japan); ISO - International Organisation for Standardization; KECI - Korea Existing Chemicals Inventory; LC50 - Lethal Concentration to 50 % of a test population; LD50 - Lethal Dose to 50% of a test population (Median
Lethal Dose); MARPOL - International Convention for the Prevention of Pollution from Ships;
n.o.s. - Not Otherwise Specified; Nch - Chilean Norm; NO(A)EC - No Observed (Adverse) EffectConcentration; NO(A)EL - No Observed (Adverse) Effect Level; NOELR - No Observable EffectLoading Rate; NOM - Official Mexican Norm; NTP - National Toxicology Program; NZIoC - New
Zealand Inventory of Chemicals; OECD - Organization for Economic Co-operation and Development; OPPTS - Office of Chemical Safety and Pollution Prevention; PBT - Persistent, Bioaccumulative and Toxic substance; PICCS - Philippines Inventory of Chemicals and Chemical Substances; (Q)SAR - (Quantitative) Structure Activity Relationship; REACH - Regulation (EC) No
1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals; SADT - Self-Accelerating Decomposition Temperature; SDS - Safety Data Sheet; TCSI - Taiwan Chemical Substance Inventory; TDG - Transportation of Dangerous Goods; TECI - Thailand Existing Chemicals Inventory; TSCA - Toxic Substances Control Act (United States); UN - United Nations; UNRTDG - United Nations Recommendations on the Transport of Dangerous Goods; vPvB - Very Persistent and Very Bioaccumulative; WHMIS - Workplace Hazardous Materials Information System
The information provided in this Safety Data Sheet is correct to the best of our knowledge, information and belief at the date of its publication. The information is designed only as a guidance forsafe handling, use, processing, storage, transportation, disposal and release and shall not be
considered a warranty or quality specification of any type. The information provided relates only
to the specific material identified at the top of this SDS and may not be valid when the SDS material is used in combination with any other materials or in any process, unless specified in the text.
Material users should review the information and recommendations in the specific context of theirintended manner of handling, use, processing and storage, including an assessment of the appropriateness of the SDS material in the user’s end product, if applicable.
JP / EN

19 / 19